Eribulin Treatment for Patients with Metastatic Breast Cancer: The UK Experience − A Multicenter Retrospective Study

INTRODUCTION: This study examined real-world data from patients who received eribulin for metastatic breast cancer (MBC) collected from 14 hospitals across the UK. METHODS: Anonymized data were collected retrospectively from patients with MBC who had received eribulin. The data included the hormone-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafri, Mariam, Kristeleit, Hartmut, Misra, Vivek, Baxter, Mark, Ahmed, Samreen, Jegannathen, Apurna, Jain, Ankit, Maskell, David, Barthakur, Urmila, Edwards, Gwenllian, Walter, Harriet S., Walshaw, Richard, Khan, Madeha, Borley, Annabel, Rea, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808648/
https://www.ncbi.nlm.nih.gov/pubmed/36044833
http://dx.doi.org/10.1159/000526140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808648/
https://www.ncbi.nlm.nih.gov/pubmed/36044833
http://dx.doi.org/10.1159/000526140

Ejemplares similares